4DMedical Expands Agreement With University of Chicago Medicine to Include Commercial CT:VQ Deployment; Shares Jump 7%

MT Newswires Live
01/30

4DMedical (ASX:4DX) expanded its partnership with the University of Chicago Medicine to include commercial deployment of CT:VQ cardiothoracic imaging product, according to a Friday Australian bourse filing.

The University of Chicago Medicine will become the fifth US academic medical center to adopt the CT:VQ product, per the filing.

The expanded arrangement includes a renewed imaging analysis platform agreement and a commercial contract, including an initial package of prepaid CT:VQ scans to boost clinical deployment.

4DMedical's shares jumped past 7% in recent Friday trade.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10